Amniotic Membrane Induces Peroxisome Proliferator-Activated Receptor-γ Positive Alternatively Activated Macrophages

被引:27
|
作者
Bauer, Dirk [1 ]
Hennig, Maren [1 ,2 ]
Wasmuth, Susanne [1 ]
Baehler, Hanna [1 ]
Busch, Martin [1 ,2 ]
Steuhl, Klaus-Peter [2 ]
Thanos, Solon [3 ]
Heiligenhaus, Arnd [1 ]
机构
[1] St Franziskus Hosp, Dept Ophthalmol, Ophtha Lab, D-48145 Munster, Germany
[2] Univ Duisburg Essen, Dept Ophthalmol, Essen, Germany
[3] Univ Munster, Sch Med, Inst Expt Ophthalmol, Munster, Germany
关键词
NF-KAPPA-B; APOPTOTIC CELLS LEADS; HERPES-SIMPLEX; PPAR-GAMMA; OXIDIZED LDL; SIGNALING PATHWAYS; STROMAL KERATITIS; LIPID-METABOLISM; HUMAN CORNEAL; NITRIC-OXIDE;
D O I
10.1167/iovs.11-7617
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Amniotic membrane transplantation (AMT) reportedly improves herpetic stromal keratitis (HSK). Here we studied the role of the amniotic membrane (AM) on macrophages. METHODS. BALB/c mice with necrotizing HSK received an AMT or tarsorrhaphy (TAR) as control. Apoptosis of F4/80+ cells was determined using the annexinV/7-AAD system. Macrophage invasion was determined using a cornea invasion assay. Cytokine secretion was quantified by ELISA. Arginase activity was measured by bioassay. Expression of nuclear factor (NF)-kappa B or peroxisome proliferator-activated receptor (PPAR)-gamma related proteins was detected by Western blot analysis, and the expression of costimulatory surface molecules or PPAR-gamma by flow cytometry. Lipid accumulation was observed by Oil red O and Sudan B staining. RESULTS. After AMT apoptotic features of corneal macrophages, but also macrophage invasion increased. IL-6, IL-10, IL-12, TNF-alpha, and NF-kappa B content in HSK corneas had decreased with AMT. AMT increased expression of PPAR-gamma, arginase 1 and 2, and arginase activity in AM-treated HSK corneas. In vitro, NF-kappa B, cytokine production, costimulatory molecules (CD80, CD86, CD40), phagocytic capacity, proliferation, viability, and accessory function to herpes simplex virus (HSV)-1 specific draining lymph node (DLN) cells were reduced in bone marrow derived macrophages (BM) cocultured with AM, while CD206, CD204, CD163, and CD68, lipid accumulation in the cytoplasm, PPAR-gamma expression, and arginase activity was increased. An increase in viability and proliferation was observed in the presence of AM combined with apoptotic cells, compared with AM alone. CONCLUSIONS. Based on these results it can be concluded that the action mechanism of AM is associated with modulation of classically activated macrophages into alternatively activated macrophages or macrophage cell death, probably by engaging lipid metabolism and activating the PPAR-gamma pathway, consequently curtailing effector T cell functions. Apoptotic cells induced in the environment with AM support the presence and survival of such macrophages. (Invest Ophthalmol Vis Sci. 2012; 53: 799-810) DOI: 10.1167/iovs.11-7617
引用
收藏
页码:799 / 810
页数:12
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide production
    Hwang, JN
    Kleinhenz, DJ
    Lassègue, B
    Griendling, KK
    Dikalov, S
    Hart, CM
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2005, 288 (04): : C899 - C905
  • [42] Mitofusin 2 decreases intracellular lipids in macrophages by regulating peroxisome proliferator-activated receptor-γ
    Liu, Chun
    Ge, Beihai
    He, Chao
    Zhang, Yi
    Liu, Xiaowen
    Liu, Kejian
    Qian, Cuiping
    Zhang, Yu
    Peng, Wenzhong
    Guo, Xiaomei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 450 (01) : 500 - 506
  • [43] Peroxisome proliferator-activated receptor-γ is deficient in alveolar macrophages from patients with alveolar proteinosis
    Bonfield, TL
    Farver, CF
    Barna, BP
    Malur, A
    Abraham, S
    Raychaudhuri, B
    Kavuru, MS
    Thomassen, MJ
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2003, 29 (06) : 677 - 682
  • [44] A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-γ activity
    Schupp, Michael
    Curtin, Joshua C.
    Kim, Roy J.
    Billin, Andrew N.
    Lazar, Mitchell A.
    MOLECULAR PHARMACOLOGY, 2007, 71 (05) : 1251 - 1257
  • [45] Cardioprotective effects of thiazolidinediones, peroxisome proliferator-activated receptor-γ agonists
    Yue, TL
    DRUGS OF TODAY, 2003, 39 (12) : 949 - 960
  • [46] Peroxisome proliferator-activated receptor-γ activity is associated with renal microvasculature
    Guan, YF
    Zhang, YH
    Schneider, A
    Davis, L
    Breyer, RM
    Breyer, MD
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (06) : F1036 - F1046
  • [47] Polymorphism in the peroxisome proliferator-activated receptor-γ gene in women with preeclampsia
    Laasanen, J
    Heinonen, S
    Hiltunen, M
    Mannermaa, A
    Laakso, M
    EARLY HUMAN DEVELOPMENT, 2002, 69 (1-2) : 77 - 82
  • [48] Variations in the peroxisome proliferator-activated receptor-γ gene and melanoma risk
    Moessner, Rotraut
    Meyer, Peter
    Jankowski, Florian
    Koenig, Inke R.
    Krueger, Ullrich
    Kammerer, Stefan
    Westphal, Goetz
    Boettger, Melanie B.
    Berking, Carola
    Schmitt, Christina
    Brockmoeller, Juergen
    Ziegler, Andreas
    Stapelmann, Henrike
    Kaiser, Rolf
    Volkenandt, Matthias
    Reich, Kristian
    CANCER LETTERS, 2007, 246 (1-2) : 218 - 223
  • [49] Peroxisome proliferator-activated receptor-γ ligands inhibit choroidal neovascularization
    Murata, T
    He, SK
    Hangai, M
    Ishibashi, T
    Xi, XP
    Kim, S
    Hsueh, WA
    Ryan, SJ
    Law, RE
    Hinton, DR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (08) : 2309 - 2317
  • [50] Peroxisome Proliferator-Activated Receptor-γ: Master Regulator of Adipogenesis and Obesity
    Shao, Xiaoru
    Wang, Meiqi
    Wei, Xueqin
    Deng, Shuwen
    Fu, Na
    Peng, Qiang
    Jiang, Yan
    Ye, Ling
    Xie, Jiamin
    Lin, Yunfeng
    CURRENT STEM CELL RESEARCH & THERAPY, 2016, 11 (03) : 282 - 289